Buy One Get One free -Llimited Time Offer X
Trazograf 0.66gm/0.1gm Infusion is a prescription medicine that is available as a Infusion. It is primarily used for the treatment of Diagnostic agent, Diagnostic agent.
The optimal dosage of Trazograf 0.66gm/0.1gm Infusion is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Trazograf 0.66gm/0.1gm Infusion include Nausea or vomiting, Shortness of Breath, Anaphylactic reaction. While these are the most often observed Trazograf 0.66gm/0.1gm Infusion side effects, there are can be others also. These have been listed below. Normally, these side effects of Trazograf 0.66gm/0.1gm Infusion are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Trazograf 0.66gm/0.1gm Infusion has a Moderate effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Trazograf 0.66gm/0.1gm Infusion's effects on the liver, heart and kidney, if any, have been listed below.
Other contraindications of Trazograf 0.66gm/0.1gm Infusion have been discussed in the sections ahead.
Drug reaction of Trazograf 0.66gm/0.1gm Infusion with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Trazograf 0.66gm/0.1gm Infusion, it is important to know that it is not safe while driving, and is not habit-forming.
Trazograf 0.66gm/0.1gm Infusion is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Trazograf 0.66gm/0.1gm Infusion is used -
Common
Unknown
Is the use of Trazograf 0.66gm/0.1gm Infusion safe for pregnant women?
Trazograf may have some side effects during pregnancy. Pregnant women should discontinue the use of Trazograf, and talk to their doctor, if they notice any discomfort.
Is the use of Trazograf 0.66gm/0.1gm Infusion safe during breastfeeding?
In the absence of any scientific study about the side effects of Trazograf in breastfeeding women, information on safety of Trazograf is unavailable.
What is the effect of Trazograf 0.66gm/0.1gm Infusion on the Kidneys?
There may be some adverse effects on kidney after taking Trazograf. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Trazograf 0.66gm/0.1gm Infusion on the Liver?
Very few cases of side effects of Trazograf on the liver have been reported.
What is the effect of Trazograf 0.66gm/0.1gm Infusion on the Heart?
There may be an adverse effect on the heart after taking Trazograf. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Trazograf 0.66gm/0.1gm Infusion unless your doctor advises you to do so -
Is this Trazograf 0.66gm/0.1gm Infusion habit forming or addictive?
Trazograf 0.66gm/0.1gm Infusion is not addictive in nature.
Interaction between Food and Trazograf 0.66gm/0.1gm Infusion
There is no information on the effects of taking Trazograf 0.66gm/0.1gm Infusion with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Trazograf 0.66gm/0.1gm Infusion
It is difficult to say anything about the effect of Trazograf 0.66gm/0.1gm Infusion and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; MD-76R [Diatrizoate Meglumine and Diatrizoate Sodium Injection]
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; MD-76®R [Diatrizoate Meglumine and Diatrizoate Sodium]